Tell us about your search experience on the TGA website - complete our short survey
TGA grants provisional determination for the Moderna COVID-19 vaccine, Elasomeran
The TGA granted provisional determination to Moderna Australia Pty Ltd in relation to the COVID-19 Vaccine, Elasomeran.
Published
Related content
- TGA provisionally approves Moderna's COVID-19 vaccineOn 9 August 2021 the TGA granted provisional approval to Moderna Australia Pty Ltd in relation to the COVID-19 vaccine, Spikevax (elasomeran), for individuals aged 18 years and over.
- TGA commences evaluation of Moderna COVID 19 vaccine (SPIKEVAX) for children aged 6 months to 5 years oldThe TGA has received and commenced evaluation of an application to extend the use of its COVID-19 vaccine, SPIKEVAX, to children aged 6 months to 5 years old.
- TGA Provisional Approval of Moderna COVID-19 vaccine to include 12-17 years age groupThe TGA has granted provisional approval to Moderna Australia Pty Ltd in relation to the COVID-19 vaccine, Spikevax (elasomeran), for individuals aged 12 years and over.